June 30, 2025

Invitation to Colonoscopy vs Fecal Immunochemical Test Screening for Colorectal Cancer

Does being invited to colorectal cancer screening with fecal immunochemical tests vs colonoscopy have an impact on colorectal cancer mortality?

The ASCO Post

June 30, 2025

Reduced-Dose Chemoradiotherapy for Early-Stage Anal Cancer

In a UK phase II trial (PLATO-ACT4) reported in The Lancet Oncology, Gilbert et al evaluated whether short-term results showed good complete response rates with both standard-dose and reduced-dose che...

The ASCO Post

June 30, 2025

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer

Results from the phase III ATOMIC study demonstrated that patients with deficient mismatch repair (dMMR) colon cancer who receive atezolizumab in addition to adjuvant chemotherapy experience a 50% red...

The ASCO Post

June 30, 2025

Five Major Advances in Radiotherapy for Anal and Rectal Cancer Presented at ESTRO 2025

Rectal cancer is one of the most common cancers in Europe, with over 125,000 people diagnosed annually. Treatment traditionally involves surgery to remove the tumor—a major operation that can permanen...

The ASCO Post

June 30, 2025

Impact of Empirical Dietary Inflammatory Pattern on Survival Outcomes in Patients With Stage III Colon Cancer

Results from a large, prospective study show that eating a less inflammatory diet may reduce the risk of death for patients with stage III colon cancer.

The ASCO Post

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 12, 2025

Vegetarian Diet Linked to Lower Cancer Incidence

A large North American cohort study found that vegetarian diets were associated with lower risks of several site-specific cancers, including colorectal, stomach, breast, prostate, and lymphoproliferative cancers.

Conexiant

June 12, 2025

What's the Best Scoring Method in CRC Prognosis?

Study of three systems finds that a simple tumor growth pattern scoring method independently predicts colon cancer–specific survival.

The Pathologist

June 06, 2025

Lower-Dose Treatment Effective in Anal Cancer Trial, Study

In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.

Conexiant